Literature DB >> 34282401

Ocular surface squamous neoplasia resistant to topical interferon alpha 2b in a patient with follicular lymphoma.

Valentin Huerva1,2,3, Magi Vilaltella1,3.   

Abstract

Entities:  

Year:  2021        PMID： 34282401      PMCID： PMC8243178          DOI： 10.18240/ijo.2021.07.24

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  10 in total

1.  Ocular surface squamous neoplasia: a standard of care survey.

Authors:  Donald U Stone; Amir L Butt; James Chodosh
Journal:  Cornea       Date:  2005-04       Impact factor: 2.651

Review 2.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

3.  Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.

Authors:  Valentín Huerva; Antonio J Mateo; Irene Mangues; Carmen Jurjo
Journal:  Cornea       Date:  2006-12       Impact factor: 2.651

Review 4.  Obinutuzumab in follicular lymphoma.

Authors:  N Martinez-Calle; R Figueroa-Mora; S Villar-Fernandez; M Marcos-Jubilar; C Panizo
Journal:  Drugs Today (Barc)       Date:  2016-12       Impact factor: 2.245

5.  Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.

Authors:  Manpreet Singh; Natasha Gautam; Manpreet Kaur
Journal:  Int Ophthalmol       Date:  2018-01-23       Impact factor: 2.031

6.  Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.

Authors:  Noy Ashkenazy; Carol L Karp; Gaofeng Wang; Carolina Mercado Acosta; Anat Galor
Journal:  Cornea       Date:  2017-04       Impact factor: 2.651

7.  A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase.

Authors:  Manuel M Paz; Xu Zhang; Jun Lu; Arne Holmgren
Journal:  Chem Res Toxicol       Date:  2012-06-25       Impact factor: 3.739

8.  Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.

Authors:  V Huerva; I Mangues
Journal:  J Fr Ophtalmol       Date:  2008-03       Impact factor: 0.818

9.  Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012.

Authors:  Eldad Adler; Joseph R Turner; Donald U Stone
Journal:  Cornea       Date:  2013-12       Impact factor: 2.651

10.  Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.

Authors:  Ibrahim O Sayed-Ahmed; Sotiria Palioura; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2016-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.